Home > Insider Trading > Filing (0001666071-21-000233)

Filing Details

Accession Number:: 0001666071-21-000233
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-06 17:08:30
Reporting Period:: 2021-12-02

Accepted Time:: 2021-12-06 17:08:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1666071	Cardlytics Inc.	CDLX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1617486	D. Scott Grimes	C/O Cardlytics, Inc. 675 Ponce De Leon Avenue Ne, Suite 6000 Atlanta GA 30308		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-12-02	1,700	$64.34	55,412	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-12-02	300	$65.23	55,112	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-12-03	1,100	$61.43	239,859	No	4	S	Direct
Common Stock	Disposition	2021-12-03	3,816	$62.23	236,043	No	4	S	Direct
Common Stock	Disposition	2021-12-03	684	$62.99	235,359	No	4	S	Direct
Common Stock	Disposition	2021-12-03	300	$64.06	235,059	No	4	S	Direct
Common Stock	Disposition	2021-12-03	100	$65.20	234,959	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019, as amended March 12, 2020.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $63.82 to $64.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (6), (7), (8), (9), and (10) to this Form 4.
The reportable securities are held by the GRAT.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $64.83 to $65.43, inclusive.
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020, as amended June 15, 2021.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $60.85 to $61.78, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $61.85 to $62.84, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $62.865 to $63.17, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $64.05 to $64.08, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $65.19 to $65.35, inclusive.